Interleukin Genetics Reports Third Quarter 2013 Financial Results

18-11-2013 Business Wire HealthComments (0)

Biotechnology

Interleukin Genetics, Inc. (OTCQB: ILIU) today issued financial and operational results for the third quarter ended September 30, 2013. “During the first nine months of 2013, we made significant progress toward commercialization of our PST® test, a transformative genetic test that predicts a patient’s risk for periodontal disease progression and therefore their need for different levels of preventive care,” said Dr. Kenneth Kornman, Chief Executive Officer of In

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top